The Quality Standards Resource Centre helps extend understanding of the strengthened Aged Care Quality Standards, which take effect from 1 November 2025. The Resource Centre will be updated to reflect key changes made to the draft strengthened Standards. You can search for resources by using keywords, or filtering by standard, outcome, audience and theme. Before using the Resource Centre, please read the terms of use.
Documentation of patient information
This resource outlines best practices for documenting patient information related to medication history and adverse drug reactions. It provides guidance on obtaining the best possible medication history (BPMH), reconciling medications at care transitions, and recording known allergies. The resource helps aged care providers ensure accurate medication management, reduce errors, and prevent harm from adverse drug events.
This resource may apply to healthcare contexts outside of aged care. Please consider the applicability of this resource to your care setting.
Guide for consumers - Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard
This resource is a guide for consumers about the Australian Commission on Safety and Quality in Health Care's Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard. The resource includes 8 quality statements about the health care consumers should receive to support the correct use of psychotropic medicines.
This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
High risk medicines resources
This resource provides guidance on high-risk medicines, including safety alerts, notices, and best practices for safe prescribing, dispensing, and administration. It includes information on insulin and anticoagulant safety, monitoring tools, and best practice recommendations to improve medication safety and reduce harm from high-risk medications across healthcare settings.
This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
Polypharmacy Consumer Perspective - National Medicines Symposium 2024
This is a presentation on Polypharmacy Consumer Perspective. It includes details of a case example, resolution and care management, and key principles related to medicines and goal of care. This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
Case study - Safe and Appropriate use of Psychotropic Medicines - Residential Aged Care
This resource is a fictional scenario that follows an older person’s care pathway with a residential aged care provider. The resource focuses on the systems and processes to support high-quality care of older people living with cognitive impairment. It includes 4 key priority areas: person-centred care, medication management, managing changed behaviours and transitions of care.
This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
Case study - Safe and Appropriate use of Psychotropic Medicines - In-home Aged Care
This resource is a fictional scenario that follows an older person’s care pathway with an in-home aged care provider. The resource focuses on the systems and processes to support high-quality care of older people living with dementia. It includes 4 key priority areas: person-centred care, medication management, managing changed behaviours and transitions of care.
This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
Safe and appropriate use of psychotropic medicines for aged care - Fact sheet
This fact sheet is informed by the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard (CCS), developed by the Australian Commission on Safety and Quality in Health Care. The CCS describes the safe and appropriate use of psychotropic medicines for people with cognitive disability or impairment, in a way that upholds their rights, dignity, health and quality of life.
This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
Clinical governance and quality improvement to support medication management
This resource outlines clinical governance and quality improvement systems to support safe medication management. It requires health service organisations to implement systems for procuring, prescribing, dispensing, and monitoring medicines.
This resource may refer to information that will be updated from 1 November 2025 to align with the new Aged Care Act and Quality Standards.
Medicines use in older people
This resource is chapter six of the Fourth Atlas 2021 of Healthcare Variations. The chapter examines medicines use in people aged 75 and over, focusing on polypharmacy, medication management reviews (MMRs), and proton pump inhibitor (PPI) dispensing. It highlights variations in medication use and recommends improving access to MMR services and interventions for safe, effective medication use in older populations.
